Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
暂无分享,去创建一个
G. Dorn | P. Halushka | P. Kochel | D. Mais | R. Burch
[1] P. Halushka,et al. Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. , 1986, The Journal of biological chemistry.
[2] P. Halushka,et al. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. , 1985, The Journal of pharmacology and experimental therapeutics.
[3] A. M. Lefer,et al. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. , 1985, The Journal of pharmacology and experimental therapeutics.
[4] P. Halushka,et al. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. , 1985, The Journal of pharmacology and experimental therapeutics.
[5] T. Pugsley,et al. A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. , 1983, Analytical biochemistry.
[6] J. Hanoune,et al. Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets. , 1982, Biochemical and biophysical research communications.
[7] A. Budzynski,et al. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. , 1981, The Journal of biological chemistry.
[8] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[9] P. Halushka,et al. Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125I , 1984 .